<?xml version="1.0" encoding="UTF-8"?>
<search_results count="384147">
  <query>ALL</query>
  <!-- Additional study fields may be added over time -->
  <study rank="1">
    <title>Osteosarcoma Maintenance Therapy With OST31-164</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Bone Cancer</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">OST31-164</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04974008</url>
  </study>
  <study rank="2">
    <title>Research on Optimization of Rotator Cuff Injury Diagnosis Plan</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Rotator Cuff Injury</condition>
    </conditions>
    <interventions>
      <intervention type="Behavioral">several physical examinations</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04973995</url>
  </study>
  <study rank="3">
    <title>ENvarsus for Impaired Glucose Tolerance Post REnal transplAnT</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Renal Transplant Failure</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Envarsus</intervention>
      <intervention type="Drug">Adoport</intervention>
    </interventions>
    <locations>
      <location>Barts Health NHS Trust, London, United Kingdom</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973982</url>
  </study>
  <study rank="4">
    <title>Follicular Challenge Test to Predict Response to GnRH Agonist Triggering</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Infertility, Female</condition>
    </conditions>
    <interventions>
      <intervention type="Other">Decapeptyl</intervention>
    </interventions>
    <locations>
      <location>Shamir medical center, Tzrifin, Israel</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973969</url>
  </study>
  <study rank="5">
    <title>Influence of Anxiety on Motor Learning, Memory and Motor Imagery Ability in Young Population</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Anxiety</condition>
    </conditions>
    <interventions>
      <intervention type="Other">Relaxation</intervention>
      <intervention type="Other">Control</intervention>
    </interventions>
    <locations>
      <location>Claude Bernard University Lyon 1, Villeurbanne, Auvergne-Rhône-Alpes, France</location>
      <location>University of Alcalá, Alcalá De Henares, Madrid, Spain</location>
      <location>Complutense University of Madrid, Pozuelo De Alarcón, Madrid, Spain</location>
      <location>European University of Madrid, Villaviciosa De Odón, Madrid, Spain</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973956</url>
  </study>
  <study rank="6">
    <title>Donor-derived Cell Free DNA as a New Biomarker in Cardiac Acute Rejection</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Heart Transplant Rejection</condition>
    </conditions>
    <interventions>
      <intervention type="Diagnostic Test">Donor-derived cell Free DNA</intervention>
    </interventions>
    <locations>
      <location>Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain</location>
      <location>University Hospital Puerta de Hierro, Majadahonda, Madrid, Spain</location>
      <location>Clinica Universitaria de Navarra, Pamplona, Navarra, Spain</location>
      <location>Hospital Universitario A Coruña, A Coruña, Spain</location>
      <location>Hospital Bellvitge, Barcelona, Spain</location>
      <location>Hospital Clinic de Barcelona, Barcelona, Spain</location>
      <location>Hospital Santa Creu i Sant Pau, Barcelona, Spain</location>
      <location>Hospital 12 octubre, Madrid, Spain</location>
      <location>Hospital Universitario Gregorio Marañón, Madrid, Spain</location>
      <location>Hospital Virgen de la Arrixaca, Murcia, Spain</location>
      <location>Hospital Virgen del Rocio, Sevilla, Spain</location>
      <location>Hospital La Fe, Valencia, Spain</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973943</url>
  </study>
  <study rank="7">
    <title>Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Major Depressive Disorder</condition>
      <condition>Breast Cancer</condition>
      <condition>Venlafaxine</condition>
    </conditions>
    <interventions>
      <intervention type="Behavioral">Interpersonal Psychotherapy</intervention>
      <intervention type="Drug">Venlafaxine HCl ER</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04973930</url>
  </study>
  <study rank="8">
    <title>A Comparison of Intellivent-ASV Mode With Conventional Modes in Patients With BMI &gt;35</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Ventilation Therapy; Complications</condition>
    </conditions>
    <interventions>
      <intervention type="Procedure">respiratory support</intervention>
    </interventions>
    <locations>
      <location>Russian research center of surgery named after academician B. V. Petrovsky, Moscow, Russian Federation</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973917</url>
  </study>
  <study rank="9">
    <title>Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Cervical Cancer</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Toripalimab</intervention>
      <intervention type="Drug">Paclitaxel</intervention>
      <intervention type="Drug">Cisplatin</intervention>
      <intervention type="Drug">Bevacizumab</intervention>
    </interventions>
    <locations>
      <location>Peking Union Medical College Hospital, Beijing, Beijing, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973904</url>
  </study>
  <study rank="10">
    <title>CANA/Met Versus Met in Non-diabetic Women With PCOS</title>
    <status open="N">Enrolling by invitation</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Polycystic Ovary Syndrome</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Canagliflozin combined with metformin</intervention>
      <intervention type="Drug">Metformin</intervention>
    </interventions>
    <locations>
      <location>Shengjing Hospital of China Medical University, Shenyang, Liaoning, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973891</url>
  </study>
  <study rank="11">
    <title>The Optimal Sequence in Same-day Bidirectional Endoscopy Under Deep Anesthesia.</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Bidirectional Endoscopy</condition>
      <condition>Deep Sedation</condition>
    </conditions>
    <interventions>
      <intervention type="Procedure">EGD first</intervention>
      <intervention type="Procedure">Colonoscopy first</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04973878</url>
  </study>
  <study rank="12">
    <title>Cross Cultural Adaptation of International Physical Activity Questionaire Short Form in Urdu Version</title>
    <status open="N">Completed</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Heart Diseases</condition>
    </conditions>
    <interventions>
      <intervention type="Other">Validation &amp; reliability</intervention>
    </interventions>
    <locations>
      <location>Pakistan Railway General Hospital, Rawalpindi, Punjab, Pakistan</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973865</url>
  </study>
  <study rank="13">
    <title>High Intensity Training Using Overground Exoskeletons</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Spinal Cord Injuries</condition>
    </conditions>
    <interventions>
      <intervention type="Device">Ekso</intervention>
    </interventions>
    <locations>
      <location>NeuroRecovery Research Center at TIRR Memorial Hermann, Houston, Texas, United States</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973852</url>
  </study>
  <study rank="14">
    <title>Optimizing the Efficacy of Progressive Muscle Relaxation Using Placebo Mechanisms in an Guided and Unguided Online-intervention</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Watching a Video Aiming to Optimize Participants' Expectations Before Undergoing a Single PMR Session Without Personal Support of the Experimenter (Unguided)</condition>
      <condition>Watching a Video Aiming to Optimize Participants' Expectations Before Undergoing a Single PMR Session With the Personal Support of the Experimenter (Guided)</condition>
      <condition>Watching a Neutral Video Before Undergoing a Single PMR Session Without Personal Support of the Experimenter (Unguided)</condition>
      <condition>Watching a Neutral Video Before Undergoing a Single PMR Session With the Personal Support of the Experimenter (Guided)</condition>
    </conditions>
    <interventions>
      <intervention type="Behavioral">Progressive Muscle Relaxation (PMR</intervention>
    </interventions>
    <locations>
      <location>Department of Psychology, Philipps University Marburg, Marburg, Hessen, Germany</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973839</url>
  </study>
  <study rank="15">
    <title>Study to Assess the Pharmacokinetics, Safety and Tolerability of Aztreonam-Avibactam in Healthy Chinese Participants.</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Healthy</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Aztreonam-Avibactam</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04973826</url>
  </study>
  <study rank="16">
    <title>Active Choice Intervention About Physical Activity for Physically Inactive Adults</title>
    <status open="N">Completed</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Physical Activity</condition>
    </conditions>
    <interventions>
      <intervention type="Behavioral">Guideline + Active Choice + action&amp;coping planning (GA+)</intervention>
      <intervention type="Behavioral">Guideline + Active Choice (GA)</intervention>
      <intervention type="Behavioral">Guideline + information (GI)</intervention>
      <intervention type="Behavioral">Guideline (G)</intervention>
    </interventions>
    <locations>
      <location>VUMedicalCenter, Amsterdam, Noord-Holland, Netherlands</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973813</url>
  </study>
  <study rank="17">
    <title>Simvastatin and Emotional Processing (OxSTEP)</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Depression</condition>
      <condition>Inflammation</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Simvastatin 20mg</intervention>
      <intervention type="Drug">Placebo</intervention>
    </interventions>
    <locations>
      <location>Department of Psychiatry, University of Oxford, Oxford, Oxfordshire, United Kingdom</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973800</url>
  </study>
  <study rank="18">
    <title>The Role of Microbiome on Biological Therapy Efficacy in axSpA and RA</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Axial Spondyloarthritis</condition>
      <condition>Arthritis, Rheumatoid</condition>
    </conditions>
    <interventions>
      <intervention type="Biological">biological disease-modifying antirheumatic drugs (bDMARDs)</intervention>
    </interventions>
    <locations>
      <location>Centro Hospitalar Baixo Vouga - Hospital Infante D. Pedro, Aveiro, Portugal</location>
      <location>Hospital de Braga, E.P.E., Braga, Portugal</location>
      <location>Hospital Sousa Martins - Unidade de Saúde Local da Guarda, Guarda, Portugal</location>
      <location>Centro Hospitalar Lisboa Ocidental - Hospital Egas Moniz, Lisboa, Portugal</location>
      <location>Centro Hospitalar Universitário de Lisboa Norte - Hospital Santa Maria, Lisboa, Portugal</location>
      <location>Instituto Português de Reumatologia, Lisboa, Portugal</location>
      <location>Centro Hospitalar Universitário São João, Oporto, Portugal</location>
      <location>Unidade Local de Saúde do Alto Minho, Hospital Conde de Bertiandos, Ponte de Lima, Portugal</location>
      <location>Centro Hospitalar de Médio Tejo - Hospital Rainha Santa Isabel - Torres Novas, Torres Novas, Portugal</location>
      <location>Centro Hospitalar de Vila Nova da Gaia/Espinho, Vila Nova De Gaia, Portugal</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973787</url>
  </study>
  <study rank="19">
    <title>A Multi-center Prospective Study of Branch Atheromatous Disease in China</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Cerebral Infarction</condition>
      <condition>Disease</condition>
      <condition>Magnetic Resonance Imaging</condition>
    </conditions>
    <interventions/>
    <locations>
      <location>Shengde li, Beijing, Beijing, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973774</url>
  </study>
  <study rank="20">
    <title>Quality of Life for Children With Zirconium Anteroir Crowns Versus Strip Composite Crowns</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Caries</condition>
    </conditions>
    <interventions>
      <intervention type="Other">Zirconium crowns</intervention>
      <intervention type="Other">Strip composite crowns</intervention>
    </interventions>
    <locations>
      <location>Minia University, Minya, Egypt</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973761</url>
  </study>
  <study rank="21">
    <title>Open-label Conditioning Therapy for Peri-operative Pain Management in Head and Neck Cancer Patients</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Postoperative Pain</condition>
      <condition>Opioid Use</condition>
    </conditions>
    <interventions>
      <intervention type="Behavioral">Open Label Conditioning</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04973748</url>
  </study>
  <study rank="22">
    <title>A Phase I Study of LY-CovMab Injection in Chinese Healthy Subjects</title>
    <status open="N">Active, not recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Covid19</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">LY-CovMab</intervention>
    </interventions>
    <locations>
      <location>The Second Hospital of Anhui Medical University, Hefei, Anhui, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973735</url>
  </study>
  <study rank="23">
    <title>A Study to Evaluate LY06006 and Prolia in Healthy Adults</title>
    <status open="N">Active, not recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Healthy Adults</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">LY06006</intervention>
      <intervention type="Drug">Prolia</intervention>
    </interventions>
    <locations>
      <location>The Third Xiangya Hospital of Central South University, Changsha, Hunan, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973722</url>
  </study>
  <study rank="24">
    <title>Prevalence of Delirium in Outpatient Clinics</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Delirium in Old Age</condition>
      <condition>Delirium Superimposed on Dementia</condition>
      <condition>Delirium With Dementia</condition>
    </conditions>
    <interventions>
      <intervention type="Diagnostic Test">Confussion assessment method (CAM)</intervention>
      <intervention type="Diagnostic Test">Dementia diagnosis</intervention>
    </interventions>
    <locations>
      <location>Gulhane training and research hospital, Ankara, Turkey</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973709</url>
  </study>
  <study rank="25">
    <title>Toolkit for Optimal Recovery After Orthopedic Injury</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Acute Orthopedic Injury</condition>
    </conditions>
    <interventions>
      <intervention type="Behavioral">Toolkit for Optimal Recovery after Orthopedic Injury</intervention>
      <intervention type="Other">Minimally Enhanced Usual Care (MEUC)</intervention>
    </interventions>
    <locations>
      <location>Massachusetts General Hospital, Boston, Massachusetts, United States</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973696</url>
  </study>
  <study rank="26">
    <title>AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Adenoid Cystic Carcinoma</condition>
      <condition>Metastatic Adenoid Cystic Carcinoma</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">AL101</intervention>
      <intervention type="Procedure">Therapeutic Conventional Surgery</intervention>
    </interventions>
    <locations>
      <location>M D Anderson Cancer Center, Houston, Texas, United States</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973683</url>
  </study>
  <study rank="27">
    <title>Protective Effect of Sivelestat Sodium on Sepsis With Respiratory Failure and Oxygenation Index &gt; 200mmHg Patients</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>ARDS</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Sivelestat sodium</intervention>
      <intervention type="Drug">Placebo</intervention>
    </interventions>
    <locations>
      <location>Nanjing Zhong-Da Hospital, Southeast University, Nanjing, Jiangsu, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973670</url>
  </study>
  <study rank="28">
    <title>A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">VK0214</intervention>
      <intervention type="Other">Placebo</intervention>
    </interventions>
    <locations>
      <location>Viking Clinical Site 203, Palo Alto, California, United States</location>
      <location>Viking Clinical Site 207, Gainesville, Florida, United States</location>
      <location>Viking Clinical Site 201, Baltimore, Maryland, United States</location>
      <location>Viking Clinical Site 206, New York, New York, United States</location>
      <location>Viking Clinical Site 205, Seattle, Washington, United States</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973657</url>
  </study>
  <study rank="29">
    <title>Combining Wearable Technology to Crate Internet+Digital Hospital-remote Home Type 2 Diabetes Follow-up Management Mode</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Diabetes Mellitus, Type 2</condition>
    </conditions>
    <interventions>
      <intervention type="Device">Remote monitoring devices+Internet management platform</intervention>
    </interventions>
    <locations>
      <location>The Second Affiliated Hospital Of Nanchang University, Nanchang, Jiangxi, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973644</url>
  </study>
  <study rank="30">
    <title>The Effects of Sex and Age Differences on Gastric Cancer : a Retrospective Study</title>
    <status open="N">Enrolling by invitation</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Sex</condition>
      <condition>Age</condition>
      <condition>Gastric Cancer</condition>
    </conditions>
    <interventions>
      <intervention type="Genetic">Sex, Age</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04973631</url>
  </study>
  <study rank="31">
    <title>Study of APVO436 in Elderly or Unfit Patients With Newly Diagnosed AML</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>AML</condition>
    </conditions>
    <interventions>
      <intervention type="Biological">APVO436</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04973618</url>
  </study>
  <study rank="32">
    <title>Treatment of Relapsed/Refractory Multiple Myeloma With t 11;14 Translocation Using BGB-11417 With Dexamethasone; Also Using BGB-11417 in Combination With Dexamethasone and Carfilzomib.</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Relapsed/Refractory Multiple Myeloma</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">BGB-11417 + Dexamethasone</intervention>
      <intervention type="Drug">BGB-11417 + Dexamethasone + Carfilzomib</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04973605</url>
  </study>
  <study rank="33">
    <title>Evaluation of Professional Practices in the Management of Blunt Abdominal Trauma in Children in the Pediatric Emergency</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Blunt Abdominal Trauma in Children</condition>
      <condition>Identifying Intra Abdominal Injuries</condition>
    </conditions>
    <interventions/>
    <locations>
      <location>Marine Pettini, Nancy, France</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973592</url>
  </study>
  <study rank="34">
    <title>Simultaneous Cardiac Surgery and Micronet-covered Stent Carotid Revascularization in High Perioperative Stroke Risk Patients</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Carotid Stenosis</condition>
      <condition>Coronary Artery Disease</condition>
      <condition>Valvular Heart Disease</condition>
      <condition>Myocardial Infarction</condition>
      <condition>Pulmonary Edema With Heart Failure</condition>
    </conditions>
    <interventions>
      <intervention type="Procedure">Simutaneous (single anaesthesia) carotid artery stenting with MicroNet covered stent (CGuard) and cardiac surgery (CABG or surgical valve replacement / repair procedure)</intervention>
    </interventions>
    <locations>
      <location>Department of Cardiac and Vascular Diseases, John Paul II Hospital, Krakow, Poland</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973579</url>
  </study>
  <study rank="35">
    <title>A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy Participants</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Healthy</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Nipocalimab</intervention>
      <intervention type="Drug">Etanercept</intervention>
      <intervention type="Drug">Hydroxychloroquine</intervention>
    </interventions>
    <locations>
      <location>PRA Health Sciences, Groningen, Netherlands</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973566</url>
  </study>
  <study rank="36">
    <title>Dose Escalation Upper Limb Rehabilitation in Stroke</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Stroke</condition>
    </conditions>
    <interventions>
      <intervention type="Other">upper limb rehabilitation</intervention>
    </interventions>
    <locations>
      <location>Ziekenhuis Oost-Limburg, Genk, Belgium</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973553</url>
  </study>
  <study rank="37">
    <title>A Clinical Trial to Evaluate the Safety and Efficacy of IBS Angel in Patients With Pulmonary Artery Stenosis</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Pulmonary Artery Stenosis</condition>
    </conditions>
    <interventions>
      <intervention type="Device">Iron Bioresorbable Scaffold System (IBS Angel)</intervention>
    </interventions>
    <locations>
      <location>Fuwai Hospital, CAMS &amp; PUMC, Beijing, China</location>
      <location>Children's Hospital of Chongqing Medical University, Chongqing, China</location>
      <location>Guangdong Provincial People's Hospital, Guangzhou, China</location>
      <location>Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China</location>
      <location>Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China</location>
      <location>General Hospital of Northern Theater Command of Chinese People's Liberation Army, Shenyang, China</location>
      <location>Shenzhen Children's Hospital, Shenzhen, China</location>
      <location>Fuwai Central China Cardiovascular Hospital, Zhengzhou, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973540</url>
  </study>
  <study rank="38">
    <title>LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T Lymphocyte Tumor</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>T Cell Lymphoma</condition>
      <condition>T-cell Leukemia</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Efficacy of LCAR-T2C CAR-T cells</intervention>
    </interventions>
    <locations>
      <location>Beijing Boren Hospital, Beijing, Beijing, China</location>
      <location>Beijing Boren Hospital, Beijing, Beijing, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973527</url>
  </study>
  <study rank="39">
    <title>Perioperative Transfusion Strategies in Adult Congenital Heart Disease Patients Undergoing Cardiac Surgery</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Congenital Heart Disease</condition>
      <condition>Cardiac Surgery</condition>
      <condition>Blood Transfusion</condition>
      <condition>Morbidity, Multiple</condition>
    </conditions>
    <interventions>
      <intervention type="Procedure">Cardiac surgery in grown-up congenital heart disease patients</intervention>
    </interventions>
    <locations>
      <location>CHU Brugmann, Brussels, Belgium</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973514</url>
  </study>
  <study rank="40">
    <title>Functional Disorders of the Musculoskeletal System in People With Multiple Sclerosis</title>
    <status open="N">Completed</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Multiple Sclerosis</condition>
      <condition>Rehabilitation</condition>
      <condition>Musculoskeletal Complication</condition>
    </conditions>
    <interventions>
      <intervention type="Behavioral">Manual physiotherapeutic correction (MFK) Method</intervention>
      <intervention type="Behavioral">Dynamic Neuromuscular Stabilization (DNS) Method</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04973501</url>
  </study>
  <study rank="41">
    <title>Therapeutic Plasma Exchange Followed by Convalescent Plasma Transfusion in Severe and Critically Ill COVID-19 Patients</title>
    <status open="N">Completed</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>COVID-19 Pneumonia</condition>
      <condition>COVID-19 Respiratory Infection</condition>
      <condition>Acute Respiratory Failure</condition>
      <condition>Acute Respiratory Distress Syndrome</condition>
    </conditions>
    <interventions>
      <intervention type="Other">Therapeutic plasma exchange</intervention>
    </interventions>
    <locations>
      <location>Municipal Hospital &quot;Dr. Teodor Andrei&quot; Lugoj, Lugoj, Timis, Romania</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973488</url>
  </study>
  <study rank="42">
    <title>Indocyanine Green Tracer Using in Laparoscopic Distal Gastrectomy for Early Gastric Cancer</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Early Gastric Cancer</condition>
      <condition>Indocyanine Green</condition>
      <condition>Lymph Node Dissection</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Indocyanine Green</intervention>
    </interventions>
    <locations>
      <location>Department of Gastric Surgery, Fuzhou, Fujian, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973475</url>
  </study>
  <study rank="43">
    <title>Evaluation of The Efficacy of Triazavirin Versus Oseltamivir in Egyptian Patients Infected With COVID-19</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Covid19</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">standard treatment COVID-19 + Triazavirin</intervention>
    </interventions>
    <locations>
      <location>Fever Hospital of the Egyptian Armed Forces, Cairo, Egypt</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973462</url>
  </study>
  <study rank="44">
    <title>Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>COVID-19</condition>
      <condition>SARS-CoV-2</condition>
    </conditions>
    <interventions>
      <intervention type="Biological">AZD1222</intervention>
      <intervention type="Biological">AZD2816</intervention>
    </interventions>
    <locations>
      <location>Research Site, Brasilia, Brazil</location>
      <location>Research Site, Curitiba, Brazil</location>
      <location>Research Site, Natal, Brazil</location>
      <location>Research Site, Natal, Brazil</location>
      <location>Research Site, Porto Alegre, Brazil</location>
      <location>Research Site, Salvador, Brazil</location>
      <location>Research Site, São Paulo, Brazil</location>
      <location>Research Site, Birmingham, United Kingdom</location>
      <location>Research Site, Bournemouth, United Kingdom</location>
      <location>Research Site, Bristol, United Kingdom</location>
      <location>Research Site, Bristol, United Kingdom</location>
      <location>Research Site, Dundee, United Kingdom</location>
      <location>Research Site, Edinburgh, United Kingdom</location>
      <location>Research Site, Hull, United Kingdom</location>
      <location>Research Site, London, United Kingdom</location>
      <location>Research Site, London, United Kingdom</location>
      <location>Research Site, London, United Kingdom</location>
      <location>Research Site, London, United Kingdom</location>
      <location>Research Site, Manchester, United Kingdom</location>
      <location>Research Site, Newcastle-upon-Tyne, United Kingdom</location>
      <location>Research Site, Nottingham, United Kingdom</location>
      <location>Research Site, Oxford, United Kingdom</location>
      <location>Research Site, Plymouth, United Kingdom</location>
      <location>Research Site, Sheffield, United Kingdom</location>
      <location>Research Site, Truro, United Kingdom</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973449</url>
  </study>
  <study rank="45">
    <title>DBT for Metastatic Lung Cancer</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Lung Cancer Metastatic</condition>
    </conditions>
    <interventions>
      <intervention type="Behavioral">Dialectical Behavioral Therapy Skills Training</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04973436</url>
  </study>
  <study rank="46">
    <title>STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Crohn Disease</condition>
      <condition>Calprotectin</condition>
      <condition>MRI</condition>
    </conditions>
    <interventions>
      <intervention type="Radiation">MRI</intervention>
    </interventions>
    <locations>
      <location>Amiens university hospital, Amiens, France</location>
      <location>Aurillac Hospital, Aurillac, France</location>
      <location>Bayonne hospital, Bayonne, France</location>
      <location>Bordeaux university hospital, Bordeaux, France</location>
      <location>Chambery Hospital, Chambéry, France</location>
      <location>Clermont-Ferrand University hospital, Clermont-Ferrand, France</location>
      <location>Grenoble University Hospital, Grenoble, France</location>
      <location>Issoire Hospital, Issoire, France</location>
      <location>LILLE university hospital, Lille, France</location>
      <location>Lyon Hospital, Hospices civils de Lyon, Lyon, France</location>
      <location>Montluçon Hospital, Montluçon, France</location>
      <location>Montpellier University hospital, Montpellier, France</location>
      <location>Nancy University hospital, Nancy, France</location>
      <location>Nice University hospital, Nice, France</location>
      <location>Rennes University Hospital, Rennes, France</location>
      <location>Saint Etienne University Hospital, Saint-Étienne, France</location>
      <location>Thiers Hospital, Thiers, France</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973423</url>
  </study>
  <study rank="47">
    <title>The Association Between Catheter-based Absolute Coronary Flow and Resistance and 15O-H2O Positron Emission Tomography Scan Based Absolute Myocardial Blood Flow in the Coronary Artery Territory</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Coronary Artery Disease</condition>
    </conditions>
    <interventions>
      <intervention type="Diagnostic Test">Coronary Physiology</intervention>
      <intervention type="Diagnostic Test">15O-H2O-PET scan</intervention>
    </interventions>
    <locations>
      <location>Aarhus University Hospital, Aarhus, Denmark</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973410</url>
  </study>
  <study rank="48">
    <title>Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Preoperative Care</condition>
      <condition>Surgery--Complications</condition>
      <condition>Myocardial Infarction</condition>
    </conditions>
    <interventions/>
    <locations>
      <location>Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada</location>
      <location>Centre hospitalier universitaire de Sherbrooke (CHUS) - Hôpital Fleurimont, Sherbrooke, Quebec, Canada</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973397</url>
  </study>
  <study rank="49">
    <title>Ocular Comorbidity in Atopic Dermatitis</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Atopic Keratoconjunctivitis</condition>
    </conditions>
    <interventions/>
    <locations>
      <location>Department of Ophthalmology, Rigshospitalet-Glostrup, Glostrup, Denmark</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973384</url>
  </study>
  <study rank="50">
    <title>Acceptability and Feasibility of Home-based TB Testing</title>
    <status open="N">Completed</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Tuberculosis, Pulmonary</condition>
      <condition>Households</condition>
    </conditions>
    <interventions>
      <intervention type="Diagnostic Test">Home-based point-of-care (POC) TB testing using GeneXpert device + MTB/RIF test</intervention>
    </interventions>
    <locations>
      <location>Buffalo City Metro, East London, Eastern Cape, South Africa</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973371</url>
  </study>
  <study rank="51">
    <title>Randomized Clinical Trial to Determine the Effect of a Mouthwash on the Preservation of the Ecology of the Oral Microbiome and Its Compatibility With Health</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Buccal Microbiota</condition>
    </conditions>
    <interventions>
      <intervention type="Other">buccotherm mouthwash</intervention>
      <intervention type="Other">placebo mouthwash</intervention>
    </interventions>
    <locations>
      <location>CHU Rennes, Rennes, France</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973358</url>
  </study>
  <study rank="52">
    <title>Terbutaline Sulfate in Adults With Asthma</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Asthma</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Terbutaline</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04973345</url>
  </study>
  <study rank="53">
    <title>Safety and Efficacy of SINOMED SR for Endovascular Treatment of Acute Ischemic Stroke</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Ischemic Stroke, Acute</condition>
      <condition>Brain Diseases</condition>
      <condition>Cerebrovascular Disorders</condition>
    </conditions>
    <interventions>
      <intervention type="Device">Intracranial thrombectomy stent</intervention>
    </interventions>
    <locations>
      <location>General Hospital of Eastern Theater Command, PLA, Nanjing, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973332</url>
  </study>
  <study rank="54">
    <title>Trastuzumab Combined With Pertuzumab for Adjuvant Treatment of Breast Cancer After Neoadjuvant Therapy</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Breast Cancer</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Pyrotinib</intervention>
      <intervention type="Drug">Trastuzumab</intervention>
    </interventions>
    <locations>
      <location>Shengjing Hospital affiliated to China Medical University, Shenyang, Liaoning, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973319</url>
  </study>
  <study rank="55">
    <title>nCRT Combined With Tislelizumab Versus nCRT for Local Advanced Esophageal Squamous Cell Carcinoma</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Esophageal Squamous Cell Carcinoma(cT1b-3N1-2M0, cT3-4aN0M0)</condition>
    </conditions>
    <interventions>
      <intervention type="Procedure">Neoadjuvant Chemoradiotherapy</intervention>
      <intervention type="Drug">Tislelizumab</intervention>
      <intervention type="Procedure">Ivor-Lewis or Mckeown Esophagectomy(Mckeown Esophagectomy recommended)</intervention>
    </interventions>
    <locations>
      <location>Shanghai Zhongshan Hospital, Shanghai, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973306</url>
  </study>
  <study rank="56">
    <title>Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Lung Neoplasm Malignant</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">sintilimab</intervention>
      <intervention type="Drug">bevacizumab</intervention>
    </interventions>
    <locations>
      <location>Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973293</url>
  </study>
  <study rank="57">
    <title>Study to Evaluate Additional Risk Minimisation Measures (aRMMs) for REBLOZYL Among Healthcare Professionals (HCPs)</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Myelodysplastic Syndromes</condition>
      <condition>Beta-thalassemia</condition>
    </conditions>
    <interventions/>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04973280</url>
  </study>
  <study rank="58">
    <title>Game Plan for PrEP</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Human Immunodeficiency Virus Exposure</condition>
      <condition>Alcohol; Harmful Use</condition>
    </conditions>
    <interventions>
      <intervention type="Behavioral">Game Plan for PrEP</intervention>
      <intervention type="Behavioral">Attention-Matched Control Lifestyle Habits Videos</intervention>
    </interventions>
    <locations>
      <location>Brown University, Providence, Rhode Island, United States</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973267</url>
  </study>
  <study rank="59">
    <title>Improving Treatment and Retention Adherence in Nontraditional Settings</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>HIV Infections</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">CAB-RPV LA delivered in community settings</intervention>
      <intervention type="Other">Standard treatment within an HIV clinic</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04973254</url>
  </study>
  <study rank="60">
    <title>Mandibular Dimensions as a Predictor of Age and Sex in a Sample of Upper Egypt Population by Using Panoramic Images and Cone Beam Computed Tomography</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Mandibular Dimensions</condition>
    </conditions>
    <interventions>
      <intervention type="Radiation">OPG &amp; CBCT</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04973241</url>
  </study>
  <study rank="61">
    <title>Trial of PDE4 Inhibition With Roflumilast for the Management of Seborrheic Dermatitis (STRATUM)</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Seborrheic Dermatitis</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">ARQ-154 - Active</intervention>
      <intervention type="Drug">ARQ-154 Vehicle</intervention>
    </interventions>
    <locations>
      <location>Arcutis Biotherapeutics Clinical Site 01, Scottsdale, Arizona, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 45, Encinitas, California, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 46, San Diego, California, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 64, San Diego, California, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 21, Santa Monica, California, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 42, Coral Gables, Florida, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 57, Delray Beach, Florida, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 33, Largo, Florida, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 31, North Miami Beach, Florida, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 65, Sanford, Florida, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 12, Tampa, Florida, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 10, Rolling Meadows, Illinois, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 03, Indianapolis, Indiana, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 22, Plainfield, Indiana, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 15, Louisville, Kentucky, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 04, Lake Charles, Louisiana, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 02, Rockville, Maryland, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 28, Rockville, Maryland, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 40, Clinton Township, Michigan, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 20, Detroit, Michigan, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 14, Fridley, Minnesota, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 44, Saint Joseph, Missouri, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 19, Reno, Nevada, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 34, East Windsor, New Jersey, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 63, Bronx, New York, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 05, Stony Brook, New York, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 23, High Point, North Carolina, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 70, Winston-Salem, North Carolina, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 18, Bexley, Ohio, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 08, Broomall, Pennsylvania, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 27, Pittsburgh, Pennsylvania, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 06, Knoxville, Tennessee, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 13, Arlington, Texas, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 11, Austin, Texas, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 41, College Station, Texas, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 60, Houston, Texas, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 26, Pflugerville, Texas, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 54, San Antonio, Texas, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 24, San Antonio, Texas, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 07, West Jordan, Utah, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 17, Norfolk, Virginia, United States</location>
      <location>Arcutis Biotherapeutics Clinical Site 35, Calgary, Alberta, Canada</location>
      <location>Arcutis Biotherapeutics Clinical Site 37, Surrey, British Columbia, Canada</location>
      <location>Arcutis Biotherapeutics Clinical Site 47, Winnipeg, Manitoba, Canada</location>
      <location>Arcutis Biotherapeutics Clinical Site 43, Fredericton, New Brunswick, Canada</location>
      <location>Arcutis Biotherapeutics Clinical Site 16, London, Ontario, Canada</location>
      <location>Arcutis Biotherapeutics Clinical Site 29, Mississauga, Ontario, Canada</location>
      <location>Arcutis Biotherapeutics Clinical Site 30, North Bay, Ontario, Canada</location>
      <location>Arcutis Biotherapeutics Clinical Site 32, Peterborough, Ontario, Canada</location>
      <location>Arcutis Biotherapeutics Clinical Site 36, Waterloo, Ontario, Canada</location>
      <location>Arcutis Biotherapeutics Clinical Site 09, Westmount, Quebec, Canada</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973228</url>
  </study>
  <study rank="62">
    <title>HealthIntro - Health Perspective in the Introduction Program</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Refugee Health</condition>
    </conditions>
    <interventions>
      <intervention type="Other">no intervention</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04973215</url>
  </study>
  <study rank="63">
    <title>Portrayal of Hospital Alcohol Detoxification in France</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Alcohol Use Disorder</condition>
      <condition>Addiction</condition>
      <condition>Alcohol Withdrawal Syndrome</condition>
    </conditions>
    <interventions>
      <intervention type="Other">Stay for alcohol detoxification</intervention>
    </interventions>
    <locations>
      <location>Uhmontpellier, Montpellier, France</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973202</url>
  </study>
  <study rank="64">
    <title>A Study of SHR-1707 in Healthy Young Adult and Elderly Subjects</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Alzheimer's Disease</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">SHR-1707</intervention>
      <intervention type="Drug">Placebo</intervention>
      <intervention type="Drug">SHR-1707</intervention>
      <intervention type="Drug">Placebo</intervention>
    </interventions>
    <locations>
      <location>The second Hospital of Anhui Medical University, Hefei, Anhui, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973189</url>
  </study>
  <study rank="65">
    <title>Standard Versus Flexible Tip Bougie for Videolaryngoscopy</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Intubation, Intratracheal</condition>
    </conditions>
    <interventions>
      <intervention type="Device">Standard Bougie</intervention>
      <intervention type="Device">Flexi-tip Bougie (P3 Medical Bristol,UK)</intervention>
    </interventions>
    <locations>
      <location>University Hospitals Coventry &amp; Warwickshire NHS Trust, Coventry, West Midlands, United Kingdom</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973176</url>
  </study>
  <study rank="66">
    <title>A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Solid Tumors, KRAS Mutation</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">BI 1823911</intervention>
      <intervention type="Drug">BI 1701963</intervention>
      <intervention type="Drug">Midazolam</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04973163</url>
  </study>
  <study rank="67">
    <title>Study on the Effect of Eye-covering Pretreatment on Acute Delirium After General Anesthesia in Pre-school Aged Children</title>
    <status open="N">Enrolling by invitation</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Ophthalmology</condition>
    </conditions>
    <interventions>
      <intervention type="Behavioral">To explore whether pretreatment with eye covering can reduce the incidence of acute delirium and the score of delirium after general anesthesia in ophthalmology pre-age children.</intervention>
    </interventions>
    <locations>
      <location>peifang Dong, Hangzhou, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973150</url>
  </study>
  <study rank="68">
    <title>A Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Light Chain (AL) Amyloidosis</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Birtamimab</intervention>
      <intervention type="Other">Placebo</intervention>
      <intervention type="Drug">Standard of Care Chemotherapy</intervention>
    </interventions>
    <locations>
      <location>Yale Cancer Center, North Haven, Connecticut, United States</location>
      <location>Johns Hopkins University, Bethesda, Maryland, United States</location>
      <location>Boston University School of Med., Boston, Massachusetts, United States</location>
      <location>Brigham and Women's Hospital, Boston, Massachusetts, United States</location>
      <location>University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States</location>
      <location>Karmanos Cancer Institute, Detroit, Michigan, United States</location>
      <location>Mayo Clinic - Minnesota, Rochester, Minnesota, United States</location>
      <location>Saint Lukes Hospital of Kansas City, Kansas City, Missouri, United States</location>
      <location>Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States</location>
      <location>Perlmutter Cancer Center - 38th Street, New York, New York, United States</location>
      <location>Duke Clinical Research Institute, Durham, North Carolina, United States</location>
      <location>Wake Forest Baptist Health - Comprehensive Cancer Center, Winston-Salem, North Carolina, United States</location>
      <location>Cleveland Clinic Main Campus, Cleveland, Ohio, United States</location>
      <location>The Ohio State University College of Medicine, Columbus, Ohio, United States</location>
      <location>University of Tennessee Medical Center, Knoxville, Tennessee, United States</location>
      <location>Baylor University Medical Center, Dallas, Texas, United States</location>
      <location>Froedtert and Medical College of Wisconsin, Milwaukee, Wisconsin, United States</location>
      <location>SESLHD: St George Hospital, Kogarah, New South Wales, Australia</location>
      <location>Icon Cancer Center, South Brisbane, Queensland, Australia</location>
      <location>Royal Adelaide Hospital, Adelaide, South Australia, Australia</location>
      <location>Eastern Health, Box Hill, Victoria, Australia</location>
      <location>Monash Medical Centre, Clayton, Victoria, Australia</location>
      <location>Barwon Health, Geelong, Victoria, Australia</location>
      <location>Royal Perth Hospital, Perth, Western Australia, Australia</location>
      <location>Tom Baker Cancer Centre, Calgary, Alberta, Canada</location>
      <location>Royal Victoria Hospital, Montréal, Quebec, Canada</location>
      <location>Fakultní Nemocnice Brno, Brno, Jihormoravsky Kraj, Czechia</location>
      <location>University Hospital Ostrava, Ostrava-Poruba, Moravian-Silesian, Czechia</location>
      <location>Všeobecná fakultní nemocnice v Praze, Praha, Prague, Czechia</location>
      <location>Odense Universitetshospital, Odense, Syddanmark, Denmark</location>
      <location>Hôpital Bretonneau, Tours Cedex 9, Centre, France</location>
      <location>Hopital Necker, Paris Cedex 15, Ill-de-France, France</location>
      <location>Pitie-Salpêtrière Hospital, Paris, Ill-de-France, France</location>
      <location>Hôpitaux de Brabois, Vandœuvre-lès-Nancy, Lorraine, France</location>
      <location>Hopital Rangueil, Toulouse Cedex 9, Midi-Pyrenees, France</location>
      <location>Hôpital Claude Huriez, Lille, Nord, France</location>
      <location>CHU Nantes, Nantes, Pays De La Loire, France</location>
      <location>Centre Hospitalier Universitaire Poitiers, Poitiers, Vienne, France</location>
      <location>Universitätsklinikum Heidelberg, Heidelberg, Baden-Wuerttemberg, Germany</location>
      <location>Uniklinik Köln, Köln, Baden-Württemberg, Germany</location>
      <location>University Medicine Mainz, Mainz, Rheinland-Pfalz, Germany</location>
      <location>Charité Campus Mitte, Berlin, Germany</location>
      <location>Alexandra General Hospital, Athens, Attica, Greece</location>
      <location>Theagenio Anti-Cancer Hospital of Thessaloniki, Thessaloníki, Central Macedonia, Greece</location>
      <location>University Hospital of Patras, Patra, Peloponnese, Greece</location>
      <location>Pécsi Tudományegyetem Klinikai Központ, Pécs, Baranya, Hungary</location>
      <location>Szent-Györgyi Albert Klinikai Központ, Szeged, Csongrad, Hungary</location>
      <location>Debreceni Egyetem Klinikai Központ, Debrecen, Hajdu-Bihar County, Hungary</location>
      <location>Semmelweis Egyetem, Budapest, Hungary</location>
      <location>Semmelweis Egyetem - I. sz. Belgyógyászati Klinika, Budapest, Hungary</location>
      <location>Dél-pesti Centrumkórház - Országos Hematológiai és Infektológiai Intézet, Budapest, Hungary</location>
      <location>Bnai Zion Medical Center, Haifa, Haifa District, Israel</location>
      <location>Rambam Medical Center, Haifa, Haifa District, Israel</location>
      <location>Hadassah Medical Center, Jerusalem, Jerusalem District, Israel</location>
      <location>Rabin Medical Center - Beilinson Hospital, Ashkelon, Southern District, Israel</location>
      <location>Samson Assuta Ashdod Hospital, Ashdod, Israel</location>
      <location>Barzilai Medical Center, Ashkelon, Israel</location>
      <location>Carmel Medical Center, Haifa, Israel</location>
      <location>Azienda Ospedaliero Universitaria Ospedali Riuniti Di Ancona, Ancona, Italy</location>
      <location>Azienda Ospedaliero-Universitaria di Bologna Policlinico Sant Orsola-Malpighi, Bologna, Italy</location>
      <location>ASST Spedali Civili, Brescia, Italy</location>
      <location>Azienda Ospedaliero - Universitaria - Policlinico - Vittorio Emanuele, Catania, Italy</location>
      <location>Fondazione IRCCS Policlinico San Matteo, Pavia, Italy</location>
      <location>Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy</location>
      <location>Umberto I - Policlinico di Roma, Roma, Italy</location>
      <location>Keimyung University Dongsan Hospital, Daegu, Gyeongsangbugdo, Korea, Republic of</location>
      <location>Severance Hospital, Seoul, Seoul Teugbyeols, Korea, Republic of</location>
      <location>Pusan National University Hospital, Busan, Korea, Republic of</location>
      <location>Kosin University Gospel Hospital, Busan, Korea, Republic of</location>
      <location>Gachon University Gil Medical Center, Incheon, Korea, Republic of</location>
      <location>Seoul National University Hospital, Seoul, Korea, Republic of</location>
      <location>Samsung Medical Center, Seoul, Korea, Republic of</location>
      <location>The Catholic University of Korea - Seoul St. Mary's Hospital, Seoul, Korea, Republic of</location>
      <location>Maastricht Universitair Medisch Centrum, Maastricht, Limburg, Netherlands</location>
      <location>Universitair Medisch Centrum Groningen, Groningen, Netherlands</location>
      <location>UMC Utrecht, Utrecht, Netherlands</location>
      <location>Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wrocławiu, Wrocław, Dolnoslaskie, Poland</location>
      <location>Uniwersyteckie Centrum Kliniczne w Gdańsku, Gdańsk, Pomorskie, Poland</location>
      <location>Hospital de Braga, Braga, Portugal</location>
      <location>Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal</location>
      <location>Hospital Universitario Son Espases, Palma De Mallorca, Balearic Islands, Spain</location>
      <location>Hospital Son Llatzer, Palma De Mallorca, Balearic Islands, Spain</location>
      <location>Institut Català d'Oncologia - Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain</location>
      <location>University Hospital Marqués de Valdecilla, Santander, Cantabria, Spain</location>
      <location>Clinica Universidad de Navarra - Pamplona, Pamplona, Navarre, Spain</location>
      <location>Hospital Universitario de Canarias, Tenerife, Santa Cruz De Tenerife, Spain</location>
      <location>Hospital Universitari Vall d'hebron, Barcelona, Spain</location>
      <location>Hospital Clinic of Barcelona, Barcelona, Spain</location>
      <location>Institut Català d'Oncologia - Hospital Duran i Reynals, Barcelona, Spain</location>
      <location>Hospital Josep Trueta ICO Girona, Girona, Spain</location>
      <location>Hospital Ramon y Cajal, Madrid, Spain</location>
      <location>Complejo Asistencial Universitario de Salamanca - Hospital Clínico, Salamanca, Spain</location>
      <location>Hospital Universitari i Politècnic la Fe, Valencia, Spain</location>
      <location>Hospital Universitario 12 de Octubre, Vila-real, Spain</location>
      <location>Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan</location>
      <location>Taipei Veterans General Hospital, Taipei, Taiwan</location>
      <location>Ankara UMF, Ankara, Turkey</location>
      <location>Gazi University, Ankara, Turkey</location>
      <location>Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey</location>
      <location>Ege Universitesi Tip Fakultesi, İzmir, Turkey</location>
      <location>University Hospitals Birmingham NHS Foundation Trust - Queen Elizabeth Hospital, Birmingham, England, United Kingdom</location>
      <location>The Newcastle Upon Tyne Hospitals NHS Foundation Trust, High Heaton, England, United Kingdom</location>
      <location>Barts Health NHS Trust, London, England, United Kingdom</location>
      <location>Univiersity College London Hospitals, London, England, United Kingdom</location>
      <location>Manchester University NHS Foundation Trust, Manchester, England, United Kingdom</location>
      <location>Nottingham University Hospitals NHS Trust, Nottingham, England, United Kingdom</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973137</url>
  </study>
  <study rank="69">
    <title>The Neuroprotective Effect of Dexmedetomidine Preserving Brain Functional Connectivity in Elderly Patients</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Anesthesia</condition>
      <condition>Dexmedetomidine</condition>
      <condition>Aging</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Dexmedetomidine</intervention>
      <intervention type="Drug">Placebo</intervention>
    </interventions>
    <locations>
      <location>Pontificia Universidad Catolica de Chile, Santiago, Metropolitana, Chile</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973124</url>
  </study>
  <study rank="70">
    <title>A Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose.</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Diabetes</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">CT-868</intervention>
      <intervention type="Drug">Placebo</intervention>
      <intervention type="Drug">Active Comparator</intervention>
    </interventions>
    <locations>
      <location>Carmot Clinical Research Unit 101, Chula Vista, California, United States</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973111</url>
  </study>
  <study rank="71">
    <title>Phase I Clinical Trial of CT0181 Cells in the Treatment of Hepatocellular Carcinoma</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Advanced Hepatocellular Carcinoma</condition>
    </conditions>
    <interventions>
      <intervention type="Biological">CT0181 Cells</intervention>
    </interventions>
    <locations>
      <location>Peking University, Beijing, Beijing, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973098</url>
  </study>
  <study rank="72">
    <title>Neck Cooling as a Non-Invasive Method to Lower Brain Temperature</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Healthy</condition>
    </conditions>
    <interventions>
      <intervention type="Device">Cold or body temperature circulated water</intervention>
    </interventions>
    <locations>
      <location>University of Vermont &amp; State Agricultural College, Burlington, Vermont, United States</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973085</url>
  </study>
  <study rank="73">
    <title>The Effect of Small Wins on Body Fat Loss</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Overweight</condition>
    </conditions>
    <interventions>
      <intervention type="Behavioral">One large reward treatment</intervention>
      <intervention type="Behavioral">Small wins treatment</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04973072</url>
  </study>
  <study rank="74">
    <title>Determining Levels of Function Associated With Permobil SmartDrive Manual Wheelchair Assist</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Wheelchairs</condition>
    </conditions>
    <interventions>
      <intervention type="Device">SmartDrive Summer</intervention>
      <intervention type="Device">SmartDrive Winter</intervention>
    </interventions>
    <locations>
      <location>University of Alberta, Edmonton, Alberta, Canada</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973059</url>
  </study>
  <study rank="75">
    <title>Tissue Oxygen Saturation for Esophagectomy</title>
    <status open="N">Completed</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Esophageal Neoplasms</condition>
      <condition>Esophagostomy Complication</condition>
      <condition>Anastomotic Leak</condition>
      <condition>Oxygen Deficiency</condition>
    </conditions>
    <interventions/>
    <locations>
      <location>Shizuoka cancer center, Nagaizumicho, Suntogun, Japan</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973046</url>
  </study>
  <study rank="76">
    <title>Effect of Tofacitinib in Treating ANCA-associated Vasculitis</title>
    <status open="N">Completed</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>ANCA Associated Vasculitis</condition>
      <condition>Drug Use</condition>
      <condition>JAK-STAT Pathway Deregulation</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Tofacitinib</intervention>
    </interventions>
    <locations>
      <location>Department of Rheumatology in Zhongshan hospital, Fudan University, Shanghai, Shanghai, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973033</url>
  </study>
  <study rank="77">
    <title>A Drug-drug Interaction Study of SHR6390 on Healthy Chinese Volunteers</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Advanced Solid Tumor</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">SHR6390、efavirenz</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04973020</url>
  </study>
  <study rank="78">
    <title>Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Oligometastatic Disease</condition>
      <condition>Liver Metastases</condition>
      <condition>Colorectal Cancer</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Gadoxetate disodium</intervention>
      <intervention type="Drug">Gadobenate dimeglumine</intervention>
    </interventions>
    <locations>
      <location>University of Colorado Hospital, Aurora, Colorado, United States</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04973007</url>
  </study>
  <study rank="79">
    <title>Laparoscopic Colectomies In Management of Colonic Cancers</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Laparoscopic Colectomy</condition>
      <condition>Cancer Colon</condition>
      <condition>Intracorporeal Anastomosis</condition>
    </conditions>
    <interventions>
      <intervention type="Procedure">laparoscopic intracorporeal versus extracorporeal anastomosis for right and left hemicolectomies</intervention>
    </interventions>
    <locations>
      <location>Sohag University Hospital, Sohag, Egypt</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04972994</url>
  </study>
  <study rank="80">
    <title>A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid Tumors</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Advanced Solid Tumors</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">ADCT-901</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04972981</url>
  </study>
  <study rank="81">
    <title>A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Polymyalgia Rheumatica</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">ABBV-154</intervention>
      <intervention type="Drug">Placebo</intervention>
      <intervention type="Drug">Glucocorticoid</intervention>
    </interventions>
    <locations>
      <location>Arthritis and Rheumatism Associates /ID# 232089, Jonesboro, Arkansas, United States</location>
      <location>St Jude Heritage Medical Group /ID# 228681, Fullerton, California, United States</location>
      <location>Care Access Research /ID# 228677, Huntington Beach, California, United States</location>
      <location>Arthritis &amp; Osteo Medical Ctr /ID# 228680, La Palma, California, United States</location>
      <location>Hans Richard Barthel, M.D., Inc /ID# 231902, Santa Barbara, California, United States</location>
      <location>Medvin Clinical Research /ID# 228675, Tujunga, California, United States</location>
      <location>Inland Rheum &amp; Osteo Med Grp /ID# 228679, Upland, California, United States</location>
      <location>Delaware Arthritis /ID# 230110, Lewes, Delaware, United States</location>
      <location>Rheumatology Associates of South Florida (RASF) - Clinical Research /ID# 232238, Boca Raton, Florida, United States</location>
      <location>International Medical Research - Daytona /ID# 228765, Daytona Beach, Florida, United States</location>
      <location>Lakes Research, LLC /ID# 228757, Miami, Florida, United States</location>
      <location>HMD Research LLC /ID# 228767, Orlando, Florida, United States</location>
      <location>Springfield Clinic /ID# 228840, Springfield, Illinois, United States</location>
      <location>Four Rivers Clinical Research /ID# 228858, Paducah, Kentucky, United States</location>
      <location>Rheumatology Consultants - Clinical Research /ID# 232137, Tupelo, Mississippi, United States</location>
      <location>Dartmouth-Hitchcock Medical Center /ID# 229557, Lebanon, New Hampshire, United States</location>
      <location>Ocean Rheumatology, PA /ID# 232539, Toms River, New Jersey, United States</location>
      <location>Hospital for Special Surgery /ID# 228577, New York, New York, United States</location>
      <location>St. Lawrence Health System /ID# 229702, Potsdam, New York, United States</location>
      <location>Paramount Medical Research Con /ID# 228839, Middleburg Heights, Ohio, United States</location>
      <location>Clinical Research Source, Inc. /ID# 231903, Perrysburg, Ohio, United States</location>
      <location>Altoona Ctr Clinical Res /ID# 232493, Duncansville, Pennsylvania, United States</location>
      <location>Articularis Healthcare Group, Inc d/b/a Low Country Rheumatology /ID# 228860, Summerville, South Carolina, United States</location>
      <location>West Tennessee Research Institute /ID# 228854, Jackson, Tennessee, United States</location>
      <location>Rheumatology Care Center PLLC /ID# 232306, Bellaire, Texas, United States</location>
      <location>Emeritus Research Sydney /ID# 229166, Botany, New South Wales, Australia</location>
      <location>Tasman Healthcare /ID# 230829, Southport, Queensland, Australia</location>
      <location>The Queen Elizabeth Hospital /ID# 229049, Woodville South, South Australia, Australia</location>
      <location>Emeritus Research /ID# 229270, Camberwell, Victoria, Australia</location>
      <location>Austin Health /ID# 229164, Heidelberg, Victoria, Australia</location>
      <location>Fiona Stanley Hospital /ID# 229050, Murdoch, Western Australia, Australia</location>
      <location>Rheuma-Zentrum Wien-Oberlaa GmbH /ID# 229436, Vienna, Wien, Austria</location>
      <location>Klinik Hietzing /ID# 229437, Vienna, Wien, Austria</location>
      <location>Rheumatology Research Associates /ID# 230363, Edmonton, Alberta, Canada</location>
      <location>The Waterside Clinic /ID# 230364, Barrie, Ontario, Canada</location>
      <location>CISSSBSL -Hopital regional de Rimouski /ID# 228394, Rimouski, Quebec, Canada</location>
      <location>Centre de Recherche Musculo-Squelettique /ID# 228392, Trois-rivières, Quebec, Canada</location>
      <location>CHU Montpellier - Hôpital Lapeyronie /ID# 228347, Montpellier, Herault, France</location>
      <location>Centre Hospitalier du Mans /ID# 229044, Le Mans CEDEX 9, Sarthe, France</location>
      <location>Hopital de la Cavale Blanche /ID# 228348, Brest, France</location>
      <location>CHRU Tours - Hopital Trousseau /ID# 228349, Chambray Les Tours, France</location>
      <location>Hopital Cochin /ID# 231800, Paris, France</location>
      <location>Medius Klinik Kirchheim /ID# 228660, Kirchheim unter Teck, Baden-Wuerttemberg, Germany</location>
      <location>Immanuel Krankenhaus Berlin /ID# 228659, Berlin-buch, Germany</location>
      <location>Charite Universitaetsmedizin Berlin - Campus Mitte /ID# 228661, Berlin, Germany</location>
      <location>MVZ Rheumatologie und Autoimmunmedizin Hamburg GmbH /ID# 228658, Hamburg, Germany</location>
      <location>Obudai Egeszsegugyi Centrum Kft. /ID# 231121, Budapest, Pest, Hungary</location>
      <location>Vital-Medicina Kft. /ID# 229674, Veszprém, Veszprem, Hungary</location>
      <location>Clinexpert Kft. /ID# 229677, Budapest, Hungary</location>
      <location>Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaz /ID# 229758, Gyula, Hungary</location>
      <location>Pest Megyei Flor Ferenc Korhaz /ID# 229676, Kistarcsa, Hungary</location>
      <location>CMED Rehabilitacios es Diagnosztikai Kozpont /ID# 230065, Szekesfehervar, Hungary</location>
      <location>Csongrad-Csanad Megyei Dr. Bugyi Istvan Korhaz /ID# 229793, Szentes, Hungary</location>
      <location>Obudai Egeszsegugyi Centrum Kft. Zalaegerszeg /ID# 229759, Zalaegerszeg, Hungary</location>
      <location>ASL 3 Genovese - Ospedale la Colletta /ID# 229282, Arenzano, Genova, Italy</location>
      <location>Azienda Ospedaliero-Universitaria di Modena /ID# 228825, Modena, Italy</location>
      <location>A.O.U. Citta della Salute e della Scienza di Torino /ID# 229080, Turin, Italy</location>
      <location>Azienda Ospedaliera Universitaria Friuli Centrale/Presidio Ospedaliero Universit /ID# 228815, Udine, Italy</location>
      <location>NHO Nagoya Medical Center /ID# 232420, Nagoya-shi, Aichi, Japan</location>
      <location>Fukui Clinic /ID# 230204, Toyohashi-shi, Aichi, Japan</location>
      <location>National Hospital Organization Shimoshizu National Hospital /ID# 230500, Yotsukaido-shi, Chiba, Japan</location>
      <location>Matsuyama Red Cross Hospital /ID# 230458, Matsuyama-shi, Ehime, Japan</location>
      <location>Sanuki Municipal Hospital /ID# 230202, Sanuki-shi, Kagawa, Japan</location>
      <location>Kuwana City Medical Center /ID# 231936, Kuwana-shi, Mie, Japan</location>
      <location>Kyushu University Beppu Hospital /ID# 232250, Beppu-shi, Oita, Japan</location>
      <location>Japanese Red Cross Okayama Hospital /ID# 230857, Okayama-shi, Okayama, Japan</location>
      <location>Tokyo Medical And Dental University, Medical Hospital /ID# 232206, Bunkyo-ku, Tokyo, Japan</location>
      <location>Toyama Prefectural Central Hospital /ID# 230616, Toyama-shi, Toyama, Japan</location>
      <location>Hanyang University Seoul Hospi /ID# 228719, Seongdong-gu, Seoul Teugbyeolsi, Korea, Republic of</location>
      <location>Severance Hospital /ID# 228785, Seoul, Seoul Teugbyeolsi, Korea, Republic of</location>
      <location>Kyungpook National Univ Hosp /ID# 228716, Daegu, Korea, Republic of</location>
      <location>ZiekenhuisGroep Twente /ID# 229071, Almelo, Netherlands</location>
      <location>Universitair Medisch Centrum Groningen /ID# 227727, Groningen, Netherlands</location>
      <location>Maastricht Universitair Medisch Centrum /ID# 227779, Maastricht, Netherlands</location>
      <location>Maasstad Ziekenhuis /ID# 228064, Rotterdam, Netherlands</location>
      <location>Viecuri Medisch Centrum /ID# 228250, Venlo, Netherlands</location>
      <location>Timaru Medical Specialists Ltd /ID# 229098, Timaru, Canterbury, New Zealand</location>
      <location>Waikato Hospital /ID# 229047, Hamilton, Waikato, New Zealand</location>
      <location>Wellington Regional Hospital /ID# 229490, Newtown Wellington, Wellington, New Zealand</location>
      <location>Optimal Clinical Trials Ltd /ID# 229048, Auckland, New Zealand</location>
      <location>Middlemore Clinical Trials /ID# 229099, Auckland, New Zealand</location>
      <location>NZOZ Biogenes Sp. z o.o. /ID# 228357, Wroclaw, Dolnoslaskie, Poland</location>
      <location>Szpital Uniwersytecki nr 2 im. dr. Jana Biziela /ID# 228353, Bydgoszcz, Kujawsko-pomorskie, Poland</location>
      <location>ReumaClinic Gabinet Reumatologiczny Izabela Domyslawska /ID# 228466, Bialystok, Podlaskie, Poland</location>
      <location>AI Centrum Medyczne Sp. z o.o. sp.k. /ID# 228951, Poznan, Wielkopolskie, Poland</location>
      <location>Ortopedyczno-Rehabilitacyjny Szpital Kliniczny im. Wiktora Degi /ID# 228314, Poznan, Wielkopolskie, Poland</location>
      <location>Hospital Unversitario Marques de Valdecilla /ID# 229297, Santander, Cantabria, Spain</location>
      <location>Hospital Universitario Canarias /ID# 229451, San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain</location>
      <location>Hospital General Universitario Gregorio Maranon /ID# 229302, Madrid, Spain</location>
      <location>Hospital Clinico Universitario San Carlos /ID# 229296, Madrid, Spain</location>
      <location>North West Anglia NHS Foundation Trust /ID# 230866, Bretton, Cambridgeshire, United Kingdom</location>
      <location>Leicester Royal Infirmary /ID# 231967, Leicester, England, United Kingdom</location>
      <location>The Royal Free London NHS Foundation Trust /ID# 231707, London, London, City Of, United Kingdom</location>
      <location>Norfolk and Norwich University Hospitals NHS Foundation Trust /ID# 231966, Norwich, Norfolk, United Kingdom</location>
      <location>Cannock Chase Hospital /ID# 230302, Cannock, United Kingdom</location>
      <location>UH Coventry &amp; Warwickshire /ID# 228588, Coventry, United Kingdom</location>
      <location>Wythenshawe Hospital University Hospital of South Manchester NHS Foundation Trus /ID# 230886, Manchester, United Kingdom</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04972968</url>
  </study>
  <study rank="82">
    <title>Predicting Dysglycemia in Individuals With Gestational Diabetes Immediately Postpartum Using Flash Glucose Monitoring</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Gestational Diabetes</condition>
      <condition>Prediabetes; Complicating Pregnancy</condition>
      <condition>Type 2 Diabetes</condition>
      <condition>Pregnancy Related</condition>
      <condition>Glucose Metabolism Disorders</condition>
      <condition>Metabolic Disease</condition>
      <condition>Endocrine System Diseases</condition>
    </conditions>
    <interventions>
      <intervention type="Device">Libre Freestyle Pro IQ</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04972955</url>
  </study>
  <study rank="83">
    <title>Targeted Immunotherapy After Myeloablative TBI-Based Conditioning &amp; AlloHCT in CAYA With High Risk T-Cell ALL &amp; Lymphoma</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>T-cell Acute Lymphoblastic Leukemia</condition>
      <condition>T-Cell Acute Lymphoblastic Lymphoma</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Daratumumab</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04972942</url>
  </study>
  <study rank="84">
    <title>Effects of Chiropractic Care on Cytokine Levels in Multiple Sclerosis</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Multiple Sclerosis, Relapsing-Remitting</condition>
    </conditions>
    <interventions>
      <intervention type="Other">Spinal Manipulation</intervention>
      <intervention type="Other">Sham Spinal Manipulation</intervention>
    </interventions>
    <locations>
      <location>University of Alabama at Birmingham, Birmingham, Alabama, United States</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04972929</url>
  </study>
  <study rank="85">
    <title>Patient Navigation-based Tobacco Harm Reduction Program Among Cancer Patients</title>
    <status open="N">Active, not recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Tobacco Use</condition>
    </conditions>
    <interventions>
      <intervention type="Other">Patient navigation-based tobacco harm reduction intervention</intervention>
    </interventions>
    <locations>
      <location>Penn State Cancer Institute, Hershey, Pennsylvania, United States</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04972916</url>
  </study>
  <study rank="86">
    <title>Impact of Malnutrition on Pharmacokinetic or Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV Co-infected Children</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Tuberculosis</condition>
      <condition>Pulmonary</condition>
    </conditions>
    <interventions/>
    <locations>
      <location>Mulago National Referral Hospital, Kampala, Uganda</location>
      <location>Mbarara Regional Hospital, Mbarara, Uganda</location>
      <location>The University Teaching Hospital, Lusaka, Zambia</location>
      <location>Arthur Davison Children Hospital, Ndola, Zambia</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04972903</url>
  </study>
  <study rank="87">
    <title>The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile Dysfunction</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Urologic Diseases</condition>
      <condition>Erectile Dysfunction With Diabetes Mellitus</condition>
    </conditions>
    <interventions>
      <intervention type="Biological">stem cells</intervention>
      <intervention type="Other">placebo</intervention>
    </interventions>
    <locations>
      <location>Universitas Indonesia, Jakarta Pusat, DKI Jakarta, Indonesia</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04972890</url>
  </study>
  <study rank="88">
    <title>Effect of Electro-acupuncture on Women With Diminished Ovarian Reserve</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Diminished Ovarian Reserve</condition>
    </conditions>
    <interventions>
      <intervention type="Other">Treatment group protocol</intervention>
      <intervention type="Other">Control group protocol</intervention>
    </interventions>
    <locations>
      <location>Department of Integrated Traditional Chinese and Western Medicine Tongji hospital of Huazhong University of Science and Technology, Wuhan, Hubei, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04972877</url>
  </study>
  <study rank="89">
    <title>Effects of Respiratory Muscle Training in Patients With Post COVID-19</title>
    <status open="N">Completed</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Covid19</condition>
    </conditions>
    <interventions>
      <intervention type="Other">Exercise training group</intervention>
      <intervention type="Other">Control training group</intervention>
    </interventions>
    <locations>
      <location>Gazi University, Çankaya, Ankara, Turkey</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04972864</url>
  </study>
  <study rank="90">
    <title>AIRB-4: Self-Determined Learning Model of Instruction</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Autism Spectrum Disorder</condition>
      <condition>Neurodevelopmental Disorders</condition>
    </conditions>
    <interventions>
      <intervention type="Behavioral">Self-Determined Learning Model of Instruction (SDLMI)</intervention>
    </interventions>
    <locations>
      <location>UC Davis MIND Institute, Davis, California, United States</location>
      <location>University of Kansas, Lawrence, Kansas, United States</location>
      <location>University of Washington, Seattle, Washington, United States</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04972851</url>
  </study>
  <study rank="91">
    <title>AIR-B4: Remaking Recess (RR)</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Autism Spectrum Disorder</condition>
      <condition>Neurodevelopmental Disorders</condition>
    </conditions>
    <interventions>
      <intervention type="Behavioral">Remaking Recess (RR)</intervention>
    </interventions>
    <locations>
      <location>University of Rochester, Rochester, New York, United States</location>
      <location>University of Pennsylvania, Philadelphia, Pennsylvania, United States</location>
      <location>University of Washington, Seattle, Washington, United States</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04972838</url>
  </study>
  <study rank="92">
    <title>AIR-B4: Mind the Gap</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Autism Spectrum Disorder</condition>
      <condition>Neurodevelopmental Disorders</condition>
    </conditions>
    <interventions>
      <intervention type="Behavioral">Mind the Gap</intervention>
    </interventions>
    <locations>
      <location>UC Davis MIND Institute, Davis, California, United States</location>
      <location>University of Kansas, Lawrence, Kansas, United States</location>
      <location>University of Rochester, Rochester, New York, United States</location>
      <location>UPENN, Philadelphia, Pennsylvania, United States</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04972825</url>
  </study>
  <study rank="93">
    <title>The Effects of Posture on Cerebral Blood Flow Velocity During the Acute Phase of Stroke</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Ischemic Stroke</condition>
      <condition>Haemorrhagic Stroke</condition>
      <condition>Cerebrovascular Accident</condition>
      <condition>Acute Stroke</condition>
    </conditions>
    <interventions/>
    <locations>
      <location>Royal Hallamshire Hospital, Sheffield, South Yorkshire, United Kingdom</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04972812</url>
  </study>
  <study rank="94">
    <title>Evaluation of the Efficacy and Safety of Autologous Fat Injection Into the Intersphincter Space in Fecal Incontinence: a Randomized, Placebo-controlled, Cross-over, Double-blind Trial</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Fecal Incontinence</condition>
    </conditions>
    <interventions>
      <intervention type="Other">injection of autologous fat at Day 0 and injection of saline at 6 months</intervention>
      <intervention type="Other">injection of saline at Day 0 and injection of autologous fat at 6 months</intervention>
    </interventions>
    <locations>
      <location>CHU Angers, Angers, France</location>
      <location>CHU Nantes, Nantes, France</location>
      <location>CHU Rennes, Rennes, France</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04972799</url>
  </study>
  <study rank="95">
    <title>Noninvasive Modulation of Motivational Brain Regions in Healthy Volunteers</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Traumatic Brain Injury</condition>
    </conditions>
    <interventions>
      <intervention type="Device">Repetitive Transcranial Magnetic Stimulation</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04972786</url>
  </study>
  <study rank="96">
    <title>Spinal Cord Injury Mental Health Functional Outcomes Improved by Mindfulness</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Spinal Cord Injuries</condition>
      <condition>Mindfulness Meditation</condition>
      <condition>Mental Health Wellness 1</condition>
    </conditions>
    <interventions>
      <intervention type="Behavioral">Mindfulness meditation (MM)</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04972773</url>
  </study>
  <study rank="97">
    <title>Baricitinib in Patients With Relapsing or naïve Dermatomyositis</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Dermatomyositis</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Baricitinib</intervention>
      <intervention type="Drug">Placebo</intervention>
    </interventions>
    <locations>
      <location>Pitie-Salpêtrière hospital APHP, Paris, France</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04972760</url>
  </study>
  <study rank="98">
    <title>The Effect of Skin Care Applied With Two Different Oils on Skin Integrity and Growth Parameters in Premature Babies</title>
    <status open="N">Active, not recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Premature Birth</condition>
      <condition>Skin Care</condition>
    </conditions>
    <interventions>
      <intervention type="Other">skin care with sunflower oil</intervention>
    </interventions>
    <locations>
      <location>Derince eğitim ve Araştırma Hastanesi, Kocaeli, İ̇zmi̇t, Turkey</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04972747</url>
  </study>
  <study rank="99">
    <title>Cohort of Premature Newborns for Charaterization of the Digestive Microbiota in Ulcerative Necrotizing Enterocolitis in Premature Infants</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Necrotizing Enterocolitis</condition>
      <condition>Premature Birth</condition>
    </conditions>
    <interventions>
      <intervention type="Biological">premature newborns developing a NEC</intervention>
      <intervention type="Biological">premature newborns without NEC</intervention>
    </interventions>
    <locations>
      <location>CHU Clermont-Ferrand, Clermont-Ferrand, France</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04972734</url>
  </study>
  <study rank="100">
    <title>SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Overweight</condition>
      <condition>Obesity</condition>
    </conditions>
    <interventions>
      <intervention type="Other">No treatment given</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT04972721</url>
  </study>
</search_results>
